323 related articles for article (PubMed ID: 33301050)
1. KOR Control over Addiction Processing: An Exploration of the Mesolimbic Dopamine Pathway.
Estave PM; Spodnick MB; Karkhanis AN
Handb Exp Pharmacol; 2022; 271():351-377. PubMed ID: 33301050
[TBL] [Abstract][Full Text] [Related]
2. Dynorphin/Kappa Opioid Receptor Signaling in Preclinical Models of Alcohol, Drug, and Food Addiction.
Karkhanis A; Holleran KM; Jones SR
Int Rev Neurobiol; 2017; 136():53-88. PubMed ID: 29056156
[TBL] [Abstract][Full Text] [Related]
3. Kappa Opioid Receptor-Induced Aversion Requires p38 MAPK Activation in VTA Dopamine Neurons.
Ehrich JM; Messinger DI; Knakal CR; Kuhar JR; Schattauer SS; Bruchas MR; Zweifel LS; Kieffer BL; Phillips PE; Chavkin C
J Neurosci; 2015 Sep; 35(37):12917-31. PubMed ID: 26377476
[TBL] [Abstract][Full Text] [Related]
4. Role of the Dynorphin/Kappa Opioid Receptor System in the Motivational Effects of Ethanol.
Anderson RI; Becker HC
Alcohol Clin Exp Res; 2017 Aug; 41(8):1402-1418. PubMed ID: 28425121
[TBL] [Abstract][Full Text] [Related]
5. Optogenetic stimulation of lateral hypothalamic orexin/dynorphin inputs in the ventral tegmental area potentiates mesolimbic dopamine neurotransmission and promotes reward-seeking behaviours.
Thomas CS; Mohammadkhani A; Rana M; Qiao M; Baimel C; Borgland SL
Neuropsychopharmacology; 2022 Feb; 47(3):728-740. PubMed ID: 34663867
[TBL] [Abstract][Full Text] [Related]
6. Stress produces aversion and potentiates cocaine reward by releasing endogenous dynorphins in the ventral striatum to locally stimulate serotonin reuptake.
Schindler AG; Messinger DI; Smith JS; Shankar H; Gustin RM; Schattauer SS; Lemos JC; Chavkin NW; Hagan CE; Neumaier JF; Chavkin C
J Neurosci; 2012 Dec; 32(49):17582-96. PubMed ID: 23223282
[TBL] [Abstract][Full Text] [Related]
7. Addiction as a stress surfeit disorder.
Koob GF; Buck CL; Cohen A; Edwards S; Park PE; Schlosburg JE; Schmeichel B; Vendruscolo LF; Wade CL; Whitfield TW; George O
Neuropharmacology; 2014 Jan; 76 Pt B(0 0):370-82. PubMed ID: 23747571
[TBL] [Abstract][Full Text] [Related]
8. Kappa-opioid receptor-dependent changes in dopamine and anxiety-like or approach-avoidance behavior occur differentially across the nucleus accumbens shell rostro-caudal axis.
Pirino BE; Spodnick MB; Gargiulo AT; Curtis GR; Barson JR; Karkhanis AN
Neuropharmacology; 2020 Dec; 181():108341. PubMed ID: 33011200
[TBL] [Abstract][Full Text] [Related]
9. Dynorphin and κ-Opioid Receptor Dysregulation in the Dopaminergic Reward System of Human Alcoholics.
Bazov I; Sarkisyan D; Kononenko O; Watanabe H; Yakovleva T; Hansson AC; Sommer WH; Spanagel R; Bakalkin G
Mol Neurobiol; 2018 Aug; 55(8):7049-7061. PubMed ID: 29383684
[TBL] [Abstract][Full Text] [Related]
10. Relative Timing Between Kappa Opioid Receptor Activation and Cocaine Determines the Impact on Reward and Dopamine Release.
Chartoff EH; Ebner SR; Sparrow A; Potter D; Baker PM; Ragozzino ME; Roitman MF
Neuropsychopharmacology; 2016 Mar; 41(4):989-1002. PubMed ID: 26239494
[TBL] [Abstract][Full Text] [Related]
11. The dynorphin/kappa opioid system as a modulator of stress-induced and pro-addictive behaviors.
Bruchas MR; Land BB; Chavkin C
Brain Res; 2010 Feb; 1314():44-55. PubMed ID: 19716811
[TBL] [Abstract][Full Text] [Related]
12. Sex Differences in Kappa Opioid Receptor Function and Their Potential Impact on Addiction.
Chartoff EH; Mavrikaki M
Front Neurosci; 2015; 9():466. PubMed ID: 26733781
[TBL] [Abstract][Full Text] [Related]
13. Antireward, compulsivity, and addiction: seminal contributions of Dr. Athina Markou to motivational dysregulation in addiction.
Koob GF
Psychopharmacology (Berl); 2017 May; 234(9-10):1315-1332. PubMed ID: 28050629
[TBL] [Abstract][Full Text] [Related]
14. The dysphoric component of stress is encoded by activation of the dynorphin kappa-opioid system.
Land BB; Bruchas MR; Lemos JC; Xu M; Melief EJ; Chavkin C
J Neurosci; 2008 Jan; 28(2):407-14. PubMed ID: 18184783
[TBL] [Abstract][Full Text] [Related]
15. A review of the kappa opioid receptor system in opioid use.
Cayir S; Zhornitsky S; Barzegary A; Sotomayor-Carreño E; Sarfo-Ansah W; Funaro MC; Matuskey D; Angarita G
Neurosci Biobehav Rev; 2024 Jul; 162():105713. PubMed ID: 38733895
[TBL] [Abstract][Full Text] [Related]
16. Crosstalk Between Kappa Opioid and Dopamine Systems in Compulsive Behaviors.
Escobar ADP; Casanova JP; Andrés ME; Fuentealba JA
Front Pharmacol; 2020; 11():57. PubMed ID: 32132923
[TBL] [Abstract][Full Text] [Related]
17. kappa-Opioid receptor signaling and brain reward function.
Bruijnzeel AW
Brain Res Rev; 2009 Dec; 62(1):127-46. PubMed ID: 19804796
[TBL] [Abstract][Full Text] [Related]
18. Kappa opioid receptor agonist U50,488 inhibits dopamine more in caudal than rostral nucleus accumbens core.
Karkhanis AN; West AM; Jones SR
Basic Clin Pharmacol Toxicol; 2023 Nov; 133(5):526-534. PubMed ID: 37539456
[TBL] [Abstract][Full Text] [Related]
19. Repeated exposure to the κ-opioid receptor agonist salvinorin A modulates extracellular signal-regulated kinase and reward sensitivity.
Potter DN; Damez-Werno D; Carlezon WA; Cohen BM; Chartoff EH
Biol Psychiatry; 2011 Oct; 70(8):744-753. PubMed ID: 21757186
[TBL] [Abstract][Full Text] [Related]
20. Long-term plasticity of corticostriatal synapses is modulated by pathway-specific co-release of opioids through κ-opioid receptors.
Hawes SL; Salinas AG; Lovinger DM; Blackwell KT
J Physiol; 2017 Aug; 595(16):5637-5652. PubMed ID: 28449351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]